Serial Number
90545043
Owner
Renagade Therapeutics LLCAttorney
Jonathan M. GelchinskyFiling Date
Feb 24, 2021
RENAGADE Trademark
Serial Number: 90545043 • Registration: 8187837
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jonathan M. Gelchinsky Pierce Atwood LLP
254 Commercial Street
Portland, ME 04101
United States
Trademark Details
Filing Date
February 24, 2021
Registration Date
March 24, 2026
Published for Opposition
January 17, 2023
Goods & Services
Pharmaceutical preparations and substances, namely, RNA therapeutics for the treatment of infectious diseases, blood disorders, and inflammation; pharmaceutical preparations, namely, RNA therapeutics for the prevention of cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, RNA therapeutics for the treatment of viral infections; pharmaceutical preparations, namely, RNA therapeutics for the treatment of cancers, inflammatory disorders, immunoregulatory disorders, and infectious disorders; pharmaceutical preparations, namely, RNA therapeutics for use in chemotherapy; pharmaceutical preparations, namely, RNA therapeutics for cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; pharmaceutical preparations, namely, antivirals; therapeutic pharmaceuticals, namely, RNA therapeutics for the treatment of cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; vaccine preparations, namely, RNA vaccine preparations; vaccines, namely, RNA vaccines; human vaccine preparations, namely, RNA vaccine preparations; medical preparations for the treatment of cancers, inflammatory disorders, immunoregulatory disorders, infectious disorders; medicinal preparations for the treatment of infectious diseases and for use in oncology; mixed biological preparations, namely, RNA therapeutics for the prevention and treatment of infectious diseases; pharmaceutical preparations, namely, RNA therapeutics for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical products, namely, RNA therapeutics for the treatment of viral and infectious diseases, for the treatment of cancer; therapeutic vaccines, namely, RNA therapeutics; all of the foregoing excluding medicinal dietary and nutritional supplements
